Skip to main content.

FSHD CTRN Partners

Avidity logo
Avidity Biosciences:
Press Release: Avidity Biosciences Enters Into Collaboration with FSHD Clinical Trial Network to Support Development of Biomarkers for Future Clinical Trial Use The MOVE+ Natural History Study will focus on developing disease progression biomarkers utilizing whole-body MRI and other tools to enhance future clinical trial design for the Facioscapulohumeral Muscular Dystrophy (FSHD) community. 
View Press Release

Dyne Therapeutics logo
Dyne Therapeutics:

FSHD Canada logo
FSHD Canada:

FSH Society logo
FSH Society:

friends of FSH research
Friends of FSH:

Fulcrum Therapeutics
Fulcrum Therapeutics:

MDA logo

National Institute of Neurological Disorders and Stroke logo
National Institute of Neurological Disorders and Stroke:

FSHD Clinical Trial Research Network

Contact Us

Michaela Walker
Project Manager